Ultime notizie per AERWINS Technologies (OTC:AWIN) Azioni

AERWINS Technologies

AERWINS Technologies Inc is Designing and Developing Manned and Unmanned Crafts for Low Altitude Airspace. It aims to realize an Air Mobility Society in which cars, specialized crafts, and drones can fly freely. It aligns vehicles with the stringent requirements of the Federal Aviation Administration's (FAA) Powered Ultra-Light Air Vehicle Category, setting a new standard for safe low-altitude manned flight.

AERWINS TECHNOLOGIES INC by AERWINS Technologies Inc.

AERWINS Technologies Inc

AERWINS Technologies Inc Warrants(03/02/2028)

Oppenheimer analyst Chris Kotowski maintains P10 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PX#NYSE">PX</a>) with a Outperform and raises the price target from $20 to $21.

News

Price Target

Analyst Ratings

Oppenheimer Maintains Outperform on P10, Raises Price Target to $21

WIIM

Marathon Petroleum shares are trading lower after Wolfe Research downgraded the stock from Outperform to Peer Perform.

SHOP

Shopify shares are trading higher after Needham initiated coverage on the stock with a Buy rating and announced a price target of $135. Additionally, Baird raised its price target from $110 to $120.

Oppenheimer analyst Chris Kotowski maintains KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) with a Outperform and raises the price target from $149 to $162.

Oppenheimer Maintains Outperform on KKR, Raises Price Target to $162

FTNT

Fortinet shares are trading higher after Barclays raised its price target on the stock from $103 to $110.

PYPL

PayPal shares are trading higher after Seaport Global upgraded the stock from Sell to Neutral.

Oppenheimer analyst Chris Kotowski maintains GCM Grosvenor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCMG#NASDAQ">GCMG</a>) with a Outperform and raises the price target from $18 to $19.

GCMG

Oppenheimer Maintains Outperform on GCM Grosvenor, Raises Price Target to $19

Oppenheimer analyst Owen Lau maintains Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) with a Outperform and raises the price target from $395 to $417.

COIN

Oppenheimer Maintains Outperform on Coinbase Global, Raises Price Target to $417

Trading Ideas

Ming Shing Group Shares Halted On Circuit Breaker To The Downside, Stock Now Down -61.1%

<a href="https://frontofficesports.com/draftkings-railbird-exchange-prediction-markets/">https://frontofficesports.com/draftkings-railbird-exchange-prediction-markets/</a>

General

DKNG

'DraftKings in Talks to Acquire Prediction Market Railbird Exchange'- Front Office Sports

Rumors

OSUR

Watching OraSure Technologies; Shares Saw A Spike In Volume, Traders Circulate Unconfirmed Rumor That Co Received Takeover Bid In June From Industry Entrepreneur

Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) has outperformed the market over the past 10 years by 43.82% on an annualized basis producing an average annual return of 55.23%. Currently, Advanced Micro Devices has a market capitalization of $235.51 billion. 
Buying $1000 In AMD: If an investor had bought $1000 of AMD stock 10 years ago, it would be worth $81,222.22 today based on a price of $145.25 for AMD at the time of writing.
<h3>Advanced Micro Devices's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752509712_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Advanced Micro Devices Stock In The Last 10 Years

Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO Jensen Huang said that the Chinese military is not using <a href="https://www.benzinga.com/topic/jensen-huang">his company's chips</a> due to export controls and tensions between the U.S. and China. 
The Details: Speaking in a CNN <a href="https://www.cnn.com/2025/07/13/world/video/gps0713-nvidia-us-china-ai">interview</a> on Sunday, Huang argued that China cannot depend on U.S.-made technology for its military needs because access to such technology could be restricted at any time.&nbsp;
"It could be limited at any time; not to mention, there's plenty of computing capacity in China already," Huang said.&nbsp;
"They don't need Nvidia's chips, certainly, or American tech stacks in order to build their military," he added.&nbsp; "They simply can't rely on it."
Read Next:<a href="https://www.benzinga.com/news/health-care/25/07/46355532/unitedhealth-hits-reset-new-head-of-medicaid-appointed-as-ceo-reshapes-team?utm_source=articleShare"> UnitedHealth Hits Reset: New Head Of Medicaid Appointed As CEO Reshapes Team</a>&nbsp;
Huang's remarks come in the context of U.S. export controls that restrict semiconductor firms from selling their most advanced AI chips to Chinese customers.&nbsp;
The Nvidia CEO reiterated his criticism of the export restrictions, saying they have been counterproductive to the United States' goal of maintaining technological leadership. 
According to Huang, for American technology to become the global standard, it must be accessible to all AI developers worldwide—including those in China, who make up about half of the global talent pool.
Industry analysts, such as Daniel Newman of The Futurum Group, note that Huang is carefully balancing relations between Washington and Beijing with an approach designed to keep Nvidia positioned for future opportunities in China while avoiding actions that could provoke U.S. policymakers.
"He needs to walk a proverbial tightrope to make sure that he doesn't rattle the Trump administration," Newman <a href="https://www.cnbc.com/2025/07/14/nvidias-jensen-huang-downplays-us-china-concerns-ahead-of-trip.html">told</a> CNBC.&nbsp;
Why It Matters: Last month, a senior U.S. government official told Reuters that Chinese AI firm DeepSeek is <a href="https://www.benzinga.com/markets/tech/25/06/46062695/nvidia-deepseek-ai-chips-us-china-military-news">actively supporting</a> China's military and intelligence agencies while finding ways to bypass American restrictions on advanced semiconductor exports.&nbsp;
DeepSeek is alleged to have used shell companies in Southeast Asia and other workarounds to obtain large quantities of Nvidia's H100 chips, which are subject to strict export controls. Multiple sources familiar with the situation confirmed that DeepSeek acquired these chips after the U.S. ban was implemented.
What Else: Huang is preparing to leave on his second trip to China this year as Nvidia works on a new chip that will meet the latest export rules.&nbsp;
Last week, Huang also met with President Donald Trump and was warned by lawmakers not to meet with Chinese companies tied to the military or intelligence agencies, or those on the U.S. restricted list.
NVDA Price Action: Nvidia shares were up 0.12% at $165.12 on Monday, according to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>. 
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46308025/get-ready-for-800-hours-of-blackouts-trumps-doe-warns?utm_source=articleShare">Get Ready For 800 Hours Of Blackouts, Trump&#8217;s DOE Warns</a>&nbsp;</li>
</ul>
Photo: Shutterstock&nbsp;

Large Cap

Management

Movers

Tech

NVDA

Nvidia's Jensen Huang: China Doesn't Need US Chips

Oppenheimer analyst Chris Kotowski maintains Blue Owl Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OWL#NYSE">OWL</a>) with a Outperform and raises the price target from $25 to $26.

Oppenheimer Maintains Outperform on Blue Owl Capital, Raises Price Target to $26

SpaceX is preparing the first of three planned launches for Project Kuiper this week, and Rocket Lab Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) selected a partner to aid in the build-out of its <a href="https://www.benzinga.com/general/space">Neutron rocket landing pad</a>. 
Here's a look at recent highlights, news catalysts and upcoming events in the <a href="https://www.benzinga.com/news/space/25/07/46276648/space-stock-watch-rocket-lab-joins-russell-1000-nasa-and-netflix-announce-streaming-deal">space stock sector.&nbsp;</a>
<h3 class="wp-block-heading">Office of Space Commerce Funding&nbsp;</h3>
More than 450 U.S. space, satellite and defense companies urged the Senate<a href="https://www.benzinga.com/markets/tech/25/07/46314220/over-400-space-companies-plead-congress-to-maintain-office-of-space-commerce-funding-report"> to maintain the</a> Office of Space Commerce's (OSC) funding at $65 million in the upcoming 2026 appropriations bill.&nbsp;
The OSC, a division within the Department of Commerce, is responsible for shaping space commerce policy and fostering the economic and technological advancement of the U.S. commercial space industry.
Read Next: <a href="https://www.benzinga.com/news/politics/25/07/46308025/get-ready-for-800-hours-of-blackouts-trumps-doe-warns?utm_source=articleShare">Get Ready For 800 Hours Of Blackouts, Trump&#8217;s DOE Warns</a>&nbsp;
<h3 class="wp-block-heading">Rocket Lab &#8211; RKLB</h3>
Rocket Lab, deemed &#8220;<a href="https://www.benzinga.com/news/25/07/46390296/rocket-lab-is-one-of-the-hottest-stocks-in-the-universe-cramer">one of the hottest stocks</a> in the universe&#8221; by Jim Cramer, announced last week that<a href="https://www.benzinga.com/pressreleases/25/07/b46355743/rocket-lab-selects-bollinger-shipyards-to-support-modification-of-neutron-landing-platform"> it had selected </a>Bollinger Shipyards to build the ocean landing platform for its Neutron reusable rocket. 
The sea-based landing platform named ‘Return On Investment&#8217; will be equipped with propulsion systems to maintain the platform&#8217;s target position, thermal protection systems to conserve electrical and other support equipment and technology for securing and processing the Neutron rocket.&nbsp;
Rocket Lab said ‘Return On Investment&#8217; is expected to enter service in 2026.
 Read Next: <a href="https://www.benzinga.com/markets/tech/25/07/46374434/joby-aviation-stock-goes-vertical-as-secret-massive-drone-achieves-9-hour-flight?utm_source=articleShare">Joby Aviation Stock Goes Vertical As Secret, Massive Drone Achieves 9-Hour Flight</a>
<h3 class="wp-block-heading">Project Kuiper &#8211; AMZN</h3>
SpaceX is set to launch a Falcon 9 rocket early Wednesday morning to deploy a payload of Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Project Kuiper satellites. The launch will be the first of three planned Falcon 9 missions <a href="https://www.aboutamazon.com/news/innovation-at-amazon/amazon-project-kuiper-spacex-launch">scheduled to support</a> the deployment of Project Kuiper satellites.&nbsp;
<h3 class="wp-block-heading">Intuitive Machines &#8211; LUNR&nbsp;</h3>
Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>)&nbsp; <a href="https://www.intuitivemachines.com/post/intuitive-machines-partners-with-space-forge-to-enable-u-s-space-based-semiconductor-manufacturing">announced a partnership</a> last week with Space Forge, Inc., a space-based semiconductor manufacturing company who intends to produce seed crystals without defects in space and return them to Earth.&nbsp;
"Manufacturing semiconductors in space offers significant performance benefits, but realizing that potential requires dependable, repeatable Earth return capability," said Michelle Flemming, President of Space Forge.&nbsp;&nbsp;
"Joining Intuitive Machines' Earth reentry effort provides a pathway for our materials science expertise to directly inform the development of a reliable return system," Flemming added.
<h3 class="wp-block-heading">AST SpaceMobile &#8211; ASTS&nbsp;</h3>
AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) continued to be one of the top trending tickers last week despite a lack of company specific news and the stock is up more than 22% over the past month.&nbsp;
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/health-care/25/07/46355532/unitedhealth-hits-reset-new-head-of-medicaid-appointed-as-ceo-reshapes-team?utm_source=articleShare">UnitedHealth Hits Reset: New Head Of Medicaid Appointed As CEO Reshapes Team</a>&nbsp;</li>
</ul>
Image: Shutterstock&nbsp;

SPACE

AMZN

ASTS

LUNR

RKLB

Space Stock Watch: SpaceX Prepares Launch For Project Kuiper, Jim Cramer Calls Rocket Lab A Buy

Shares of Tilray Brands Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) are trading higher Monday morning, building on a recent rally fueled by heavy trading volume and company announcements. The cannabis giant&#8217;s stock has been a focal point for investors in recent sessions, driven by a combination of high short interest and <a href="https://www.benzinga.com/cannabis">positive industry news</a>.
What To Know: Over the trailing week, Tilray stock has surged approximately 23%. This investor enthusiasm was partly attributed to the company&#8217;s <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46325962/whats-going-on-with-tilray-brands-stock-3">recent shareholder approval</a> for a potential reverse stock split and the announcement of an expansion of its <a href="https://www.benzinga.com/cannabis/25/06/46072540/tilray-makes-history-first-to-import-and-sell-branded-medical-cannabis-in-italy">medical cannabis operations</a> in Italy. 
The substantial short interest in the stock, with nearly 20% of its float held by short sellers, has also likely contributed to a short squeeze, further propelling the price upward.
Adding to the positive sentiment, California state senators last Thursday <a href="https://www.marijuanamoment.net/california-senators-approve-bill-to-pause-newly-enacted-marijuana-tax-hike-for-five-years/">unanimously approved</a> a bill to pause a newly enacted cannabis tax hike for five years. The measure, which now moves forward, aims to provide relief to the state&#8217;s struggling legal cannabis industry. 
While not yet law, this political momentum in a key market is being viewed as a significant potential tailwind for cannabis companies like Tilray, which stand to benefit from a more favorable tax environment.
Benzinga Edge Rankings: According to <a href="http://benzinga.grsm.io/register174">Benzinga Edge</a> stock rankings, Tilray currently presents a mixed but compelling profile for investors. The stock scores exceptionally high on Value, with a rating of 80.55, suggesting that its shares may be undervalued compared to its industry peers or its fundamental financial health. This could signal a potential buying opportunity for those focused on value investing. 
However, this strength is offset by significantly weaker scores in other categories. Tilray&#8217;s Momentum score is a low 5.26, and its Growth score is 21.75, indicating that the stock has been underperforming in price movement and lacks strong growth indicators.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, TLRY shares are trading higher by 7.6% to 62 cents Monday morning. The stock has a 52-week high of $2.15 and a 52-week low of $0.35.
Read Also: <a href="https://www.benzinga.com/cannabis/25/06/46006019/exclusive-medical-cannabis-is-growing-and-profitable-says-aurora-ceo-investors-are-just-missing-the-story">EXCLUSIVE: Medical Cannabis Is Growing And Profitable, Says Aurora CEO — Investors Are Just Missing The Story</a>
<h2 class="wp-block-heading">How To Buy TLRY Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Tilray Brands&#8217; case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

TLRY

Tilray Brands Stock Is Climbing Monday: What's Driving The Action?

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) blasted through <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46388685/bitcoin-shatters-all-time-high-to-hit-123000-as-ethereum-cracks-3000-and-xrp-taps-3">$123,000 on Monday</a> — just as Capitol Hill kicks off Crypto Week, a rare bipartisan push to pass sweeping digital asset legislation. With the Clarity Act and stablecoin oversight bills set for a vote, investors are eyeing what could be a regulatory green light for serious institutional capital to flood into the space.
And the biggest beneficiaries? Not just Bitcoin itself, but Bitcoin proxies such as Strategy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) and miners like MARA Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>).
Read Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46392541/how-donald-trumps-big-beautiful-bill-was-a-big-beautiful-boost-for-bitcoin">How Donald Trump&#8217;s &#8216;Big Beautiful Bill&#8217; Was A &#8216;Big Beautiful Boost&#8217; For Bitcoin</a>
<h2 class="wp-block-heading">Miners Could Rocket On Clarity And Short Squeezes</h2>
As of June 30, MARA held 49,940 BTC, yet the stock still carries a massive 26% short interest. If Bitcoin&#8217;s momentum continues and regulation gives Wall Street the green light, MARA could be primed for a short squeeze-fueled breakout. 
Other mining names like Riot Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) and CleanSpark Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) are also poised to benefit from rising Bitcoin prices, especially as institutional traders pile into regulated vehicles like BlackRock's iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>).
The risk? 
Post-halving profitability remains tight for miners. Power costs and potential tariff-driven input inflation could compress margins just as demand spikes. But with Bitcoin hitting all-time highs and regulatory clarity emerging, the market may overlook these near-term headwinds in favor of momentum — and FOMO.
<h2 class="wp-block-heading">Strategy's Bitcoin Bet Looks Brilliant — Or Leveraged</h2>
Then there's Strategy, which now holds a staggering 597,325 BTC, valued near $73.5 billion. With Bitcoin's breakout, Michael Saylor's all-in strategy looks vindicated — on paper. But Strategy remains a high-beta play, heavily exposed to Bitcoin price swings and carrying leverage risk. Still, with the stock often moving multiples of Bitcoin's gains, the upside in a regulatory tailwind scenario is hard to ignore.
Social media chatter hints at a potential $2-3 trillion wave of institutional capital waiting for clear rules. If Crypto Week delivers even modest progress, it could set off a moonshot for miners and Bitcoin-heavy stocks.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46394828/bitcoin-eth-xrp-solana-are-in-for-a-long-and-exhausting-bull-market-bernstein-predicts">Bitcoin, ETH, XRP, Solana Are In For A &#8216;Long And Exhausting Bull Market,&#8217; Bernstein Predicts</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Government

Long Ideas

Markets

$BTC

CLSK

IBIT

MARA

MSTR

RIOT

Bitcoin's $123K Boom Meets Crypto Week: Blastoff Moment For MicroStrategy, Marathon Digital?

CELC

CELC stock has given up its prior gain. Celcuity shares were trading higher after the company announced it was granted the issuance of a new U.S. patent for Gedatolisib and expects to provide topline results for PIK3CA in Q3.

PHGE

PHGE stock has given up its prior gain. BiomX shares were trading higher after the company announced the initiation of its Phase 2b trial with the first patient dosed in its BX004 program for the treatment of cystic fibrosis.

Barclays analyst Christine Cho maintains Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) with a Underweight and lowers the price target from $40 to $28.

Comments

AERWINS Technologies

Notizie

Ultime notizie per AERWINS Technologies (OTC:AWIN) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO